openPR Logo
Press release

The Global Alzheimer's Disease Therapeutics and Diagnostics Market to Progress with 5.56% of CAGR by 2028

08-23-2022 08:45 AM CET | Health & Medicine

Press release from: Triton Market Research

Global Alzheimer's Disease Therapeutics and Diagnostics Market

Global Alzheimer's Disease Therapeutics and Diagnostics Market

Triton Market Research presents the Global Alzheimer's Disease Therapeutics and Diagnostics Market report segmented by Therapeutics and Diagnostics (Therapeutics {Therapeutics by Drugs [Marketed Drugs, Pipeline Drugs], Therapeutics by Disease Stage [Late Stage: Severe AD, Early/Middle Stage: Mild to Moderate AD, Prodromal Stage], Therapeutics by Generic and Branded [Branded, Generic]}, Diagnostics {Lumbar Puncture Test, Positron Emission Tomography (PET), Electroencephalography, Magnetic Resonance Imaging, Computed Tomography, Blood Test, Other Diagnostics}) and by Geographical Region (North America, Europe, Asia-Pacific, Latin America, the Middle East and Africa), discussing Market Summary, Industry Outlook, Key Insights, Impact of COVID-19, Porter's Five Forces Analysis, Key Buying Impact Analysis, Industry Components, Different Phases Of Alzheimer's Disease, Market Attractiveness Index, Vendor Scorecard, Key Strategic Developments, Drivers, Challenges, Opportunities, Competitive Landscape, Research Methodology & Scope, Global Market Size, Forecasts & Analysis (2021-2028).

Triton Market Research, in its report on the Global Alzheimer's Disease Therapeutics and Diagnostics Market, implies that this industry is expected to progress at a CAGR of 5.56% during the forecasting period (2021-2028).

Request a Free Sample Report @

As per estimates, nearly 5.8 million people in the United States have Alzheimer's dementia. By 2050, this number is expected to rise to 13.8 million. Thus, the growing prevalence of dementia in developing countries is a major factor that is expected to fuel the growth of the market in the coming years.

However, the failure of the late-stage drugs to induce significant improvement of symptoms and stringent regulations regarding drug development and clinical trials are hampering the market growth process.

The market in North America currently leads the global market, with the largest share. It is expected to continue its stronghold in the years to come. There is a high population comprising elderly adults present in the region, who form a major patient base for dementia and Alzheimer's. This has led to an increased demand for AD therapeutics and diagnostics here.

Moreover, there are several research studies being conducted in the US for the development of novel therapeutics and diagnostics for the disease, which are being supported by new product launches. For instance, C2N Diagnostics launched PrecivityAD in November 2020, which is the world's first blood test to measure amyloid levels in the blood for Alzheimer's diagnosis. All these factors are anticipated to boost the studied market growth in the region.

Sun Pharmaceuticals Industries Ltd, Zydus Cadila, Allergan Plc acquired by Abbvie, Biogen Inc, Pfizer Inc, Teva Pharmaceutical Industries Limited, Luye Pharma Group, GE Healthcare, Eli Lilly & Company, Cognoptix Inc, Eisai Co Ltd, Amarantus Bioscience Holdings Inc, Siemens Healthineers AG, Novartis AG, F Hoffmann La Roche, Lupin Limited, Merck & Co Inc, Baxter International Inc, PeopleBio Co, and Johnson & Johnson are the eminent players present in this market.

The competition among players in this industry has increased significantly with the introduction of generics. Furthermore, this industry is also observing meaningful strategic collaborations among different players. For instance, Johnson & Johnson and GE Healthcare have formed entered into a partnership for a project that aims to find pre-symptomatic biomarkers for AD. Recent developments with respect to regulatory guidelines and disease biomarkers are expected to open new gateways for innovation in this field, which is expected to generate opportunities for new players to step into this market.

Read More @

Purchase this report @

Triton Market Research
196, wards wharf approach
London E16 2EQ
Phone: +44 7441 911839

We are a leading market research company with offices in the UK, providing the best online market research and data search reports to our clients.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The Global Alzheimer's Disease Therapeutics and Diagnostics Market to Progress with 5.56% of CAGR by 2028 here

News-ID: 2712612 • Views: 198

More Releases from Triton Market Research

The Global Class D Audio Amplifier Market to Reap $5176.17 Million by 2028
According to Triton Market Research's report, the global class D audio amplifier market garnered $2611.46 million in 2021, and is set to showcase a 10.56% of CAGR by 2028. A recent study by Triton Market Research titled 'Global Class D Audio Amplifier Market,' covers the Global Analysis and Forecasts by End-user (Consumer Electronics, Automotive, Other End-users), by Type (Mono-channel, 2 Channel, 4 Channel, 6 Channel, Other Amplifier Types), by Application (Desktops
The Global Biochar Market Estimated to Gain $3171.02 Million in Revenue by 2028
According to Triton's report, the global biochar market, which garnered $1320.94 million in 2021, is expected to grow at 13.40% of CAGR by 2028. A recent study by Triton Market Research titled 'Global Biochar Market' entails the Global Analysis and Forecasts by Feedstock (Forestry Waste, Biomass Plantation, Residential Waste, Animal Manure, Agriculture Waste), Application (Air, Soil, and Water Treatment, Horticulture, Agriculture and Livestock, Industries), Technology (Microwave Pyrolysis, Intermediate Pyrolysis, Slow
Global Base Oil Market Estimated to Gain $37.51 Billion in Value by 2028
Triton's market report shows that the global base oil market, which attained $29.70 billion in 2021, is expected to register progress at 3.42% CAGR by 2028. A recent study by Triton Market Research titled 'Global Base Oil Market' involves the Global Analysis and Forecasts by Application (Industrial Oil, Greases, Metalworking Fluids, Hydraulic Oil, Automotive Oil, Other Applications), by Group (Group I, Group II, Group III, Group IV, Group V), and
Global Automotive Paints and Coatings Market Estimated to Gain $12.55 Billion in …
According to Triton's market report, the global automotive paints and coatings market attained $8.85 billion in 2021 and is expected to register a growth at 4.97% of CAGR by 2028. A recent study by Triton Market Research titled 'Global Automotive Paints & Coatings Market' contains Global Analysis and Forecasts by Product Type (Solvent-Borne, Waterborne, Other Coatings), Coat Type (Base Coat, Electro Coat, Clear Coat, Primer), Vehicle Type (Passenger Vehicles, Light Commercial

All 5 Releases

More Releases for Therapeutics

Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025. North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant
Pruritus Drug Market – Key Players are Cara Therapeutics, Enteris BioPharma, N …
The Pruritus Drug Market research report is a significant investigation of changing business sector elements, driving elements, impediments, and limitations that have been considered the most extensive impacts on market development. Adroit investigative devices, for example, Porter’s Five Forces examination, SWOT examination, and Feasibility examination study have likewise been utilized by the report to offer an exhaustive information of the market. It will go about as a key research report
Dravet Syndrome Therapeutics- Pipeline Analysis 2018 | Zogenix, Inc., Ovid Thera …
Dravet syndrome is a form of severe myoclonic epilepsy that occurs in infants during their first year of age. If left untreated, it can be associated with other types of seizures, and status epilepticus. Children having Dravet syndrome are generally observed with poor cognitive skills and hyperactivity. Download the sample report @ It severely affects the person’s quality of life and around 10-20% of the patient are estimated to die due
Global mRNA Cancer Vaccines and Therapeutics Market to 2025| Moderna Therapeutic …
Researchmoz added Most up-to-date research on "Global mRNA Cancer Vaccines and Therapeutics Market Size, Status and Forecast 2019-2025" to its huge collection of research reports. mRNA Cancer Vaccines and Therapeutics Market report includes (6 Year Forecast 2019-2025) includes Overview, classification, industry value, price, cost and gross profit. It also offers in-intensity insight of the mRNA Cancer Vaccines and Therapeutics industry masking all vital parameters along with, Drivers, Market Trends, Market Dynamics,
Global Pruritus Therapeutics Market Report 2019 Companies included Actavis, Trev …
Market Reports Company has recently published 7th edition of Pruritus Therapeutics Market Report which covers historic data of year 2013 to 2018 along with a forecast till year 2026. For inquiry or free sample pages email us at: The report provides a comprehensive view on the current state and future prospects of the market which analyzes different strategies for business growth. The global Pruritus Therapeutics market was valued at USD xx
MRNA Vaccines & Therapeutics Market 2019 Global Analysis By Key Players – Mode …
WiseGuyReports.Com Publish a New Market Research Report On –“ MRNA Vaccines & Therapeutics Market 2019 Global Analysis By Key Players – Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics”. Description:- The mRNA Vaccines & Therapeutics industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, mRNA Vaccines & Therapeutics market size to maintain the average annual growth rate of XXX from